BSI members work throughout the entire Immunology chain, stretching from the laboratory bench through to the clinics and hospitals in which patients are treated.

The fields in which they work are diverse, from HIV/AIDS to allergy, diabetes, malaria, tuberculosis, animal health, arthritis, transplantation, vaccination and infectious disease.

[1] The BSI’s main objective is to promote and support excellence in research, scholarship and clinical practice in immunology for the benefit of human and animal health and welfare.

The BSI seeks to help British Immunology accomplish the highest possible goals.

[2] To meet this objective, the BSI undertakes the following:[2] The incumbent President of the Board of Trustees is Professor Peter Openshaw (Imperial College London) The Board of Trustees is composed of: Dr Lindsay Nicholson (University of Bristol), Professor Anne Cooke (University of Cambridge), Professor Robert Barker (University of Aberdeen), Dr Leonie Taams (King's College London), Dr Diane Williamson (DSTL), Dr Bill Egner (Sheffield Teaching Hospitals NHS Foundation Trust), Dr Sheena Cruickshank (University of Manchester)[3] The BSI is a member society of the following organisations:[4]